Erytech Pharma S.A.

Company Listings from SPi: Erytech Pharma S.A.

You are here: Home >> SPi Company Listings >> Erytech Pharma S.A.

 

Erytech Pharma S.A.

Website:
http://

Search for other references to "erytech" on SPi News

Latest Erytech Pharma S.A. News

Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2018 LYON, France, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment B -  ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Sele...... 17:00 GMT Wednesday 5th December 2018

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- The partnership encompasses NYBC becoming a long-term supplier of donor red blood cells (RBC) to ERYTECH, en...... 21:05 GMT Thursday 15th November 2018

ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update LYON, France and CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) --                     As a reminder, ERYTECH management will hold a conference call and we...... 21:30 GMT Monday 12th November 2018

Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2018 LYON, France, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment B -  ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Sele...... 17:00 GMT Monday 5th November 2018

ERYTECH to Host KOL Breakfast Symposium with Audio Webcast on November 7, 2018 LYON, France and CAMBRIDGE, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- The event will feature four guest speakers, who will highlight the treatment landscape and unmet medical need...... 06:00 GMT Monday 5th November 2018

ERYTECH Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer LYON, France and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- The TRYbeCa1 (NCT03665441) trial will enroll approximately 500 patients with second line metastatic pancreat...... 06:30 GMT Thursday 20th September 2018

ERYTECH to Attend Upcoming Investor Conferences LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies for rare...... 06:30 GMT Thursday 13th September 2018

ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update Conference call and webcast scheduled for Tuesday, September 11at 2:30 pm CET/8:30 am EDTLYON , France and CAMBRIDGE, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- As a reminder, ER...... 21:30 GMT Monday 10th September 2018

ERYTECH to Host Second Quarter 2018 Conference Call and Business Update LYON, France, Sept. 06, 2018 (GLOBE NEWSWIRE) -- The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: :The webcast can be followed live...... 06:30 GMT Thursday 6th September 2018

ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon...... 21:30 GMT Tuesday 17th July 2018

Buy Erytech Pharma S.A.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us